Your browser doesn't support javascript.
loading
Effects of the FGF receptor-1 inhibitor, infigratinib, with or without sildenafil, in experimental pulmonary arterial hypertension.
Felix, Nathane Santanna; de Mendonça, Lucas; Braga, Cassia Lisboa; da Silva, Jaqueline Soares; Samary, Cynthia Dos Santos; Vieira, Juliana Borges; Cruz, Fernanda; Rocha, Nazareth de Novaes; Zapata-Sudo, Gisele; Rocco, Patricia Rieken Macedo; Silva, Pedro Leme.
Afiliação
  • Felix NS; Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Institute of Public Health Studies, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • de Mendonça L; National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Brazil.
  • Braga CL; Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Institute of Public Health Studies, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • da Silva JS; National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Brazil.
  • Samary CDS; Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Institute of Public Health Studies, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Vieira JB; National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Brazil.
  • Cruz F; Laboratory of Cardiovascular Pharmacology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Rocha NN; Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Institute of Public Health Studies, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Zapata-Sudo G; National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Brazil.
  • Rocco PRM; Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Institute of Public Health Studies, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Silva PL; National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Brazil.
Br J Pharmacol ; 176(23): 4462-4473, 2019 12.
Article em En | MEDLINE | ID: mdl-31351013
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Pirimidinas / Receptor Tipo 1 de Fator de Crescimento de Fibroblastos / Citrato de Sildenafila / Hipertensão Arterial Pulmonar / Anti-Hipertensivos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Pirimidinas / Receptor Tipo 1 de Fator de Crescimento de Fibroblastos / Citrato de Sildenafila / Hipertensão Arterial Pulmonar / Anti-Hipertensivos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article